OpenEvidence
Medical information and clinical decision-support company providing an AI platform that synthesizes peer-reviewed research, guidelines and licensed medical content for clinicians.
October 20261
Oct 9, 2026OpenEvidence open roles snapshotOpen roles
A third-party jobs tracker listed nine open roles at OpenEvidence.
September 20264
Sep 28, 2026OpenEvidence used regularly by more than half of U.S. physiciansUser count
OpenEvidence reported regular use by more than half of U.S. physicians.
Sep 28, 2026OpenEvidence confirms additional $250M fundingFunding round
OpenEvidence confirmed an additional $250 million funding round led by Andreessen Horowitz and Byers Capital.
Sep 23, 2026OpenEvidence begins global localized rolloutAnnouncedProduct launch
OpenEvidence announced a localized version of its clinical decision-support platform for healthcare providers across roughly 100 low- and middle-income countries.
Sep 23, 2026OpenEvidence and Anthropic partner on global medical AI accessAnnouncedPartnership
OpenEvidence and Anthropic partnered to offer a localized clinical decision-support experience free to healthcare providers across roughly 100 low- and middle-income countries.
January 20263
Jan 21, 2026OpenEvidence used daily by over 40% of U.S. physiciansUser count
OpenEvidence reported daily active use by more than 40% of U.S. physicians across over 10,000 hospitals and medical centers.
Jan 21, 2026OpenEvidence surpasses $100M annual revenueRevenue disclosure
OpenEvidence reported surpassing $100 million in annual revenue.
Jan 21, 2026OpenEvidence raises $250M Series DFunding round
OpenEvidence raised $250 million in a Series D co-led by Thrive Capital and DST Global.
December 20251
Dec 31, 2025OpenEvidence reaches 18M monthly clinical consultationsUser count
OpenEvidence reported supporting approximately 18 million clinical consultations from verified U.S. healthcare professionals during December 2025.
October 20251
Oct 20, 2025OpenEvidence raises $200M Series CFunding round
OpenEvidence raised approximately $200 million in a Series C led by GV.
July 20251
Jul 15, 2025OpenEvidence raises $210M Series BFunding round
OpenEvidence raised $210 million in Series B financing to scale its medical information platform.
February 20251
Feb 20, 2025OpenEvidence raises $75M Series AFunding round
OpenEvidence raised $75 million in a Series A led by Sequoia Capital.
January 20231
2023OpenEvidence launches medical information platformProduct launch
OpenEvidence launched an AI medical information platform for physicians, providing cited answers grounded in medical journals and clinical data.
* Market cap / valuation. Company values are AI-attributed: the latest market cap or valuation × the share attributed to AI (100% for pure AI companies). Methodology